Lamprene®/Clofazimine, is a product of the pharmaceutical company named Novartis Pharmaceuticals Corporation. Lamprene®/Clofazimine is approved by FDA (the U.S Food and Drug Administration) for the treatment of leprosy. It is no longer available through pharmacies in the US. It is being tested in non-Novartis clinical studies for drug resistant tuberculosis and non-tuberculous mycobacteria (NTM). To be eligible for participation in this expanded access program, patients must have an NTM diagnosis. The treating physician has decided that this infection can be treated with Lamprene®/Clofazimine. This medicine is provided to the physician in an expanded access program. This means that this medicine is not registered for the treatment of NTM, but it can be used in special situations where there are no other possible treatments. For example, this may be because the patient has a type of Mycobacterial infection that is resistant or failed to respond optimally to other drugs, or because the patient has had side effects that prevent the use of other drugs. The physician must submit a patient registration form to initiate the patient approval process.
Drug: Lamprene®/Clofazimine
All participants will receive Lamprene/clofazimine 50 mg capsules. The recommended dose of clofazimine for this program is 100 mg once daily, administered orally, preferably with meals. Duration of treatment will be decided by the treating physician. When considering clofazimine for the treatment of NTM infection, clofazimine is to be administered as part of a multi-drug regimen.
Inclusion Criteria: 1. Male or female patients 18 years of age or older 2. Written informed consent must be obtained before any project specific assessment is performed. 3. Patients previously diagnosed with NTM infection with local or disseminated infection(i.e. patients with any NTM species at any site of infection) 4. Patients who failed or are intolerant of prior therapies or who have baseline macrolide resistance or for whom an appropriate regimen cannot otherwise be devised 5. Male patients (including vasectomized patients) who agree to use a condom during intercourse while taking clofazimine treatment and for at least 4 months after stopping treatment with clofazimine 6. Female patients of child-bearing potential with negative pregnancy test before clofazimine treatment initiation and who confirm no intention to become pregnant during the treatment with clofazimine, by using highly effective methods of contraception (methods that result in less than 1% pregnancy rates) while taking clofazimine treatment and for at least 4 months after stopping treatment with clofazimine
Exclusion Criteria: 1. History of hypersensitivity to any drugs or metabolites of similar chemical classes as clofazimine 2. History or current diagnosis of clinically significant ECG abnormalities that pose a safety risk for the patient, such as clinically significant cardiac arrhythmias (e.g.,sustained ventricular tachycardia, second or third degree heart block without a pacemaker) 3. History or additional risk factors for Torsades de Pointes such as heart failure, clinically relevant hypokalemia, familial long QT syndrome or known family history of Torsades de Pointes 4. Confirmed demonstration of resting QTcF >500 msec at screening 5. Any condition (social, psychiatric, or medical) which in the opinion of the treating physician would make participation in this MPP unsafe 6. Unable to swallow capsules 7. HIV-infected patients with disseminated NTM infection 8. Life expectancy less than 6 months 9. Pregnant or nursing (lactating) females
Novartis Investigative Site
Birmingham, Alabama, 35205
Novartis Investigative Site
Birmingham, Alabama, 35233-1711
Novartis Investigative Site
Birmingham, Alabama, 35294-0006
Novartis Investigative Site
Birmingham, Alabama, 35294
Novartis Investigative Site
Mobile, Alabama, 36608-1128
Novartis Investigative Site
Anchorage, Alaska, 99508
Novartis Investigative Site
Phoenix, Arizona, 85006
Novartis Investigative Site
Phoenix, Arizona, 85013
Novartis Investigative Site
Phoenix, Arizona, 85032
Novartis Investigative Site
Phoenix, Arizona, 85054
Novartis Investigative Site
Little Rock, Arkansas, 72205
Novartis Investigative Site
Bellflower, California, 90706
Novartis Investigative Site
Duarte, California, 91010
Novartis Investigative Site
Fontana, California, 92335
Novartis Investigative Site
Loma Linda, California, 92354
Novartis Investigative Site
Los Angeles, California, 90005-1752
Novartis Investigative Site
Los Angeles, California, 90017
Novartis Investigative Site
Los Angeles, California, 90033-4605
Novartis Investigative Site
Los Angeles, California, 90033
Novartis Investigative Site
Los Angeles, California, 90036
Novartis Investigative Site
Los Angeles, California, 90048
Novartis Investigative Site
Los Angeles, California, 90073
Novartis Investigative Site
Los Angeles, California, 90095-1752
Novartis Investigative Site
Los Angeles, California, 90095-1793
Novartis Investigative Site
Los Angeles, California, 90095
Novartis Investigative Site
Palo Alto, California, 94304
Novartis Investigative Site
Panorama City, California, 91402
Novartis Investigative Site
Pasadena, California, 91105
Novartis Investigative Site
San Diego, California, 92103
Novartis Investigative Site
San Diego, California, 92134
Novartis Investigative Site
San Francisco, California, 94143
Novartis Investigative Site
San Jose, California, 95119 1130
Novartis Investigative Site
San Luis Obispo, California, 93401
Novartis Investigative Site
Santa Barbara, California, 93105
Novartis Investigative Site
Santa Monica, California, 90404
Novartis Investigative Site
Stanford, California, 94305
Novartis Investigative Site
Torrance, California, 90509
Novartis Investigative Site
Travis Air Force Base, California, 94535
Novartis Investigative Site
Walnut Creek, California, 94598
Novartis Investigative Site
Denver, Colorado, 80205
Novartis Investigative Site
Denver, Colorado, 80206
Novartis Investigative Site
Denver, Colorado, 80218
Novartis Investigative Site
Fort Collins, Colorado, 80526
Novartis Investigative Site
Wheat Ridge, Colorado, 80033
Novartis Investigative Site
Danbury, Connecticut, 06810
Novartis Investigative Site
Waterbury, Connecticut, 06708
Novartis Investigative Site
Newark, Delaware, 19713
Novartis Investigative Site
Newark, Delaware, 19718
Novartis Investigative Site
Wilmington, Delaware, 19718
Novartis Investigative Site
Washington, District of Columbia, 20007
Novartis Investigative Site
Washington, District of Columbia, 20016
Novartis Investigative Site
Washington, District of Columbia, 20057
Novartis Investigative Site
Washington, District of Columbia, 20307-0003
Novartis Investigative Site
Aventura, Florida, 33180
Novartis Investigative Site
Delray Beach, Florida, 33445
Novartis Investigative Site
Fort Lauderdale, Florida, 33308
Novartis Investigative Site
Fort Myers, Florida, 33908
Novartis Investigative Site
Gainesville, Florida, 32610
Novartis Investigative Site
Hollywood, Florida, 33021
Novartis Investigative Site
Jacksonville, Florida, 32207
Novartis Investigative Site
Jacksonville, Florida, 32224
Novartis Investigative Site
Kissimmee, Florida, 34741
Novartis Investigative Site
Leesburg, Florida, 34748
Novartis Investigative Site
Miami Beach, Florida, 33140
Novartis Investigative Site
Miami, Florida, 33136
Novartis Investigative Site
Miami, Florida, 33173
Novartis Investigative Site
Naples, Florida, 34102
Novartis Investigative Site
Orlando, Florida, 32803
Novartis Investigative Site
Orlando, Florida, 32804
Novartis Investigative Site
Orlando, Florida, 32806
Novartis Investigative Site
Sarasota, Florida, 34239
Novartis Investigative Site
South Miami, Florida, 33143
Novartis Investigative Site
Tampa, Florida, 33606
Novartis Investigative Site
Tampa, Florida, 33612
Novartis Investigative Site
Tampa, Florida, 33614
Novartis Investigative Site
Weston, Florida, 33331
Novartis Investigative Site
Winter Park, Florida, 32792
Novartis Investigative Site
Atlanta, Georgia, 30309
Novartis Investigative Site
Atlanta, Georgia, 30322
Novartis Investigative Site
Atlanta, Georgia, 30342
Novartis Investigative Site
Augusta, Georgia, 30912
Novartis Investigative Site
Decatur, Georgia, 30033
Novartis Investigative Site
Honolulu, Hawaii, 96813
Novartis Investigative Site
Honolulu, Hawaii, 96814
Novartis Investigative Site
Lihue, Hawaii, 96766
Novartis Investigative Site
Boise, Idaho, 83712
Novartis Investigative Site
Chicago, Illinois, 60612
Novartis Investigative Site
Chicago, Illinois, 60616
Novartis Investigative Site
Chicago, Illinois, 60637
Novartis Investigative Site
Peoria, Illinois, 61637
Novartis Investigative Site
Springfield, Illinois, 62703
Novartis Investigative Site
Urbana, Illinois, 61801
Novartis Investigative Site
Indianapolis, Indiana, 46202-5111
Novartis Investigative Site
Indianapolis, Indiana, 46202
Novartis Investigative Site
Clive, Iowa, 50325
Novartis Investigative Site
Iowa City, Iowa, 52242
Novartis Investigative Site
Fairway, Kansas, 66205
Novartis Investigative Site
Kansas City, Kansas, 66160-7820
Novartis Investigative Site
Kansas City, Kansas, 66160
Novartis Investigative Site
Westwood, Kansas, 66205
Novartis Investigative Site
Wichita, Kansas, 67230
Novartis Investigative Site
Lexington, Kentucky, 40503
Novartis Investigative Site
Lexington, Kentucky, 40511
Novartis Investigative Site
Lexington, Kentucky, 40536
Novartis Investigative Site
Paducah, Kentucky, 42001
Novartis Investigative Site
Baton Rouge, Louisiana, 70808
Novartis Investigative Site
Baton Rouge, Louisiana, 70809
Novartis Investigative Site
New Orleans, Louisiana, 70112-1328
Novartis Investigative Site
New Orleans, Louisiana, 70112-2699
Novartis Investigative Site
New Orleans, Louisiana, 70112
Novartis Investigative Site
New Orleans, Louisiana, 70115
Novartis Investigative Site
New Orleans, Louisiana, 70121
Novartis Investigative Site
Baltimore, Maryland, 21201
Novartis Investigative Site
Baltimore, Maryland, 21204
Novartis Investigative Site
Baltimore, Maryland, 21224
Novartis Investigative Site
Baltimore, Maryland, 21287
Novartis Investigative Site
Bethesda, Maryland, 20892
Novartis Investigative Site
Columbia, Maryland, 21045
Novartis Investigative Site
Largo, Maryland, 20774
Novartis Investigative Site
Boston, Massachusetts, 02111
Novartis Investigative Site
Boston, Massachusetts, 02114
Novartis Investigative Site
Boston, Massachusetts, 02115
Novartis Investigative Site
Boston, Massachusetts, 02178
Novartis Investigative Site
Boston, Massachusetts, 02215
Novartis Investigative Site
Burlington, Massachusetts, 01805
Novartis Investigative Site
Cambridge, Massachusetts, 02138
Novartis Investigative Site
Framingham, Massachusetts, 01702
Novartis Investigative Site
Jamaica Plain, Massachusetts, 02130
Novartis Investigative Site
Springfield, Massachusetts, 01104
Novartis Investigative Site
Worcester, Massachusetts, 01665
Novartis Investigative Site
Ann Arbor, Michigan, 48109-5848
Novartis Investigative Site
Ann Arbor, Michigan, 48109
Novartis Investigative Site
Bloomfield Hills, Michigan, 48302
Novartis Investigative Site
Dearborn, Michigan, 48126
Novartis Investigative Site
Detroit, Michigan, 48201
Novartis Investigative Site
Detroit, Michigan, 48202 2689
Novartis Investigative Site
Detroit, Michigan, 48202
Novartis Investigative Site
Flint, Michigan, 48503
Novartis Investigative Site
Grand Rapids, Michigan, 49503
Novartis Investigative Site
Jackson, Michigan, 49202
Novartis Investigative Site
Livonia, Michigan, 48154
Novartis Investigative Site
Royal Oak, Michigan, 48073
Novartis Investigative Site
Sterling Heights, Michigan, 48314
Novartis Investigative Site
Duluth, Minnesota, 55805
Novartis Investigative Site
Mankato, Minnesota, 56001
Novartis Investigative Site
Minneapolis, Minnesota, 55455
Novartis Investigative Site
Rochester, Minnesota, 55905
Novartis Investigative Site
Saint Paul, Minnesota, 55101
Novartis Investigative Site
Saint Paul, Minnesota, 55130
Novartis Investigative Site
Gulfport, Mississippi, 39501
Novartis Investigative Site
Jackson, Mississippi, 39202
Novartis Investigative Site
Jackson, Mississippi, 39216-4505
Novartis Investigative Site
Kansas City, Missouri, 66160
Novartis Investigative Site
Saint Louis, Missouri, 63104
Novartis Investigative Site
Saint Louis, Missouri, 63110
Novartis Investigative Site
Billings, Montana, 59101
Novartis Investigative Site
Lincoln, Nebraska, 68506
Novartis Investigative Site
Omaha, Nebraska, 68114
Novartis Investigative Site
Omaha, Nebraska, 68131
Novartis Investigative Site
Omaha, Nebraska, 68198
Novartis Investigative Site
Henderson, Nevada, 89052
Novartis Investigative Site
Las Vegas, Nevada, 89106
Novartis Investigative Site
Pahrump, Nevada, 89048
Novartis Investigative Site
Reno, Nevada, 89502
Novartis Investigative Site
Lebanon, New Hampshire, 03756
Novartis Investigative Site
Flemington, New Jersey, 08822
Novartis Investigative Site
Hillsborough, New Jersey, 08844
Novartis Investigative Site
Morristown, New Jersey, 07962
Novartis Investigative Site
Newark, New Jersey, 07112
Novartis Investigative Site
Northfield, New Jersey, 08225
Novartis Investigative Site
Somers Point, New Jersey, 08244
Novartis Investigative Site
Albuquerque, New Mexico, 87131
Novartis Investigative Site
Bronx, New York, 10461
Novartis Investigative Site
Bronx, New York, 10467
Novartis Investigative Site
Brooklyn, New York, 11219
Novartis Investigative Site
Flushing, New York, 11355
Novartis Investigative Site
Manhasset, New York, 11030
Novartis Investigative Site
New York, New York, 10003
Novartis Investigative Site
New York, New York, 10016
Novartis Investigative Site
New York, New York, 10017
Novartis Investigative Site
New York, New York, 10021
Novartis Investigative Site
New York, New York, 10028
Novartis Investigative Site
New York, New York, 10029
Novartis Investigative Site
New York, New York, 10032
Novartis Investigative Site
New York, New York, 10065
Novartis Investigative Site
New York, New York, 110032
Novartis Investigative Site
Rochester, New York, 14609
Novartis Investigative Site
Rochester, New York, 14642
Novartis Investigative Site
Stony Brook, New York, 11794-8173
Novartis Investigative Site
Syracuse, New York, 13210
Novartis Investigative Site
Watertown, New York, 13601
Novartis Investigative Site
White Plains, New York, 10604
Novartis Investigative Site
Asheville, North Carolina, 28803
Novartis Investigative Site
Chapel Hill, North Carolina, 27514
Novartis Investigative Site
Chapel Hill, North Carolina, 27599-7075
Novartis Investigative Site
Chapel Hill, North Carolina, 27599-7600
Novartis Investigative Site
Chapel Hill, North Carolina, 27599-9500
Novartis Investigative Site
Chapel Hill, North Carolina, 27599
Novartis Investigative Site
Durham, North Carolina, 27705
Novartis Investigative Site
Durham, North Carolina, 27710
Novartis Investigative Site
Greensboro, North Carolina, 27401
Novartis Investigative Site
Wilmington, North Carolina, 28401
Novartis Investigative Site
Winston-Salem, North Carolina, 27157
Novartis Investigative Site
Cincinnati, Ohio, 45219
Novartis Investigative Site
Cincinnati, Ohio, 45220
Novartis Investigative Site
Cincinnati, Ohio, 45267-0585
Novartis Investigative Site
Cincinnati, Ohio, 45267
Novartis Investigative Site
Cleveland, Ohio, 44195
Novartis Investigative Site
Columbus, Ohio, 43210
Novartis Investigative Site
Dayton, Ohio, 45404-1815
Novartis Investigative Site
Lakewood, Ohio, 44107
Novartis Investigative Site
Toledo, Ohio, 43606
Novartis Investigative Site
Toledo, Ohio, 43608
Novartis Investigative Site
Toledo, Ohio, 43614
Novartis Investigative Site
Oklahoma City, Oklahoma, 73112
Novartis Investigative Site
Tulsa, Oklahoma, 74136
Novartis Investigative Site
Clackamas, Oregon, 97015
Novartis Investigative Site
Medford, Oregon, 97504
Novartis Investigative Site
Portland, Oregon, 97123
Novartis Investigative Site
Portland, Oregon, 97201
Novartis Investigative Site
Portland, Oregon, 97239
Novartis Investigative Site
Abington, Pennsylvania, 19001
Novartis Investigative Site
Allentown, Pennsylvania, 18103
Novartis Investigative Site
Bryn Mawr, Pennsylvania, 19010
Novartis Investigative Site
Danville, Pennsylvania, 17822
Novartis Investigative Site
Doylestown, Pennsylvania, 18901
Novartis Investigative Site
Drexel Hill, Pennsylvania, 19026
Novartis Investigative Site
Erie, Pennsylvania, 16507
Novartis Investigative Site
Greensburg, Pennsylvania, 15604
Novartis Investigative Site
Hershey, Pennsylvania, 17033
Novartis Investigative Site
Philadelphia, Pennsylvania, 19104 4283
Novartis Investigative Site
Philadelphia, Pennsylvania, 19104-4283
Novartis Investigative Site
Philadelphia, Pennsylvania, 19104
Novartis Investigative Site
Philadelphia, Pennsylvania, 19107
Novartis Investigative Site
Philadelphia, Pennsylvania, 19140
Novartis Investigative Site
Pittsburgh, Pennsylvania, 15213-3403
Novartis Investigative Site
Pittsburgh, Pennsylvania, 15213
Novartis Investigative Site
Pittsburgh, Pennsylvania, 15224
Novartis Investigative Site
Pittsburgh, Pennsylvania, 15243
Novartis Investigative Site
Southampton, Pennsylvania, 18966
Novartis Investigative Site
Wilkes-Barre, Pennsylvania, 18711
Novartis Investigative Site
Wyomissing, Pennsylvania, 19610
Novartis Investigative Site
Providence, Rhode Island, 02906
Novartis Investigative Site
Charleston, South Carolina, 29425
Novartis Investigative Site
Greenville, South Carolina, 29605
Novartis Investigative Site
Greenville, South Carolina, 29615
Novartis Investigative Site
Spartanburg, South Carolina, 29303
Novartis Investigative Site
West Columbia, South Carolina, 29169
Novartis Investigative Site
Sioux Falls, South Dakota, 57105
Novartis Investigative Site
Chattanooga, Tennessee, 37403
Novartis Investigative Site
Chattanooga, Tennessee, 37404
Novartis Investigative Site
Jackson, Tennessee, 38305
Novartis Investigative Site
Knoxville, Tennessee, 37920
Novartis Investigative Site
Memphis, Tennessee, 38103
Novartis Investigative Site
Memphis, Tennessee, 38104
Novartis Investigative Site
Memphis, Tennessee, 38157
Novartis Investigative Site
Dallas, Texas, 75246
Novartis Investigative Site
Dallas, Texas, 75390
Novartis Investigative Site
El Paso, Texas, 79905
Novartis Investigative Site
Galveston, Texas, 77555-0783
Novartis Investigative Site
Houston, Texas, 77025
Novartis Investigative Site
McKinney, Texas, 75069
Novartis Investigative Site
San Antonio, Texas, 78229-4404
Novartis Investigative Site
San Antonio, Texas, 78229
Novartis Investigative Site
San Antonio, Texas, 78284
Novartis Investigative Site
The Woodlands, Texas, 77385
Novartis Investigative Site
Tyler, Texas, 75708
Novartis Investigative Site
Salt Lake City, Utah, 84108
Novartis Investigative Site
Salt Lake City, Utah, 84132
Novartis Investigative Site
Annandale, Virginia, 22003-7360
Novartis Investigative Site
Annandale, Virginia, 22003
Novartis Investigative Site
Arlington, Virginia, 22205
Novartis Investigative Site
Charlottesville, Virginia, 22908-0334
Novartis Investigative Site
Charlottesville, Virginia, 22911
Novartis Investigative Site
Portsmouth, Virginia, 23708
Novartis Investigative Site
Richmond, Virginia, 23298
Novartis Investigative Site
Salem, Virginia, 24153
Novartis Investigative Site
Everett, Washington, 98201
Novartis Investigative Site
Kirkland, Washington, 98034
Novartis Investigative Site
Seattle, Washington, 98108
Novartis Investigative Site
Seattle, Washington, 98109
Novartis Investigative Site
Tacoma, Washington, 98405
Novartis Investigative Site
Morgantown, West Virginia, 26506
Novartis Investigative Site
Eau Claire, Wisconsin, 54701
Novartis Investigative Site
Greenfield, Wisconsin, 53221
Novartis Investigative Site
Milwaukee, Wisconsin, 53215
Novartis Investigative Site
Milwaukee, Wisconsin, 53226
Novartis Investigative Site
Milwaukee, Wisconsin, 53233
Novartis Investigative Site
Milwaukee, Wisconsin, 55902
Novartis Pharmaceuticals
1-888-669-6682
Novartis.email@novartis.com
Novartis Pharmaceuticals
+41613241111